Henry E. Pelish, Chief Scientific Officer at Nuvalent, Inc. (NUVL), sold 3,093 shares at $104.27 ($323K) on 2026-04-09, disclosed to the SEC on 2026-04-13.
Scheduled sale ($323k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.27 | 2,193 | $229K | 70.8% |
| 2 | $105.00 | 900 | $95K | 29.2% |
| Total | $104.48 avg | 3,093 | $323K | 100% |
| Filing → |
| NUVL | SELL | 2026-01-07 | $502K | — | Filing → |
| NUVL | SELL | 2025-10-17 | $2.6M | — | Filing → |
| NUVL | SELL | 2025-10-15 | $1.8M | — | Filing → |